Skip to main content
Premium Trial:

Request an Annual Quote

Sanofi Solicits Harvard's Help

In an effort to bolster its translational biomedical research portfolio, Sanofi-Aventis is headed to Harvard. Researchers at Sanofi and Harvard will collaborate on a number of projects, including those focused on cancer, diabetes, and inflammation. For its part, the company "will periodically evaluate technologies that may be of interest which are identified by Harvard's Office of Technology Development" and "will host an annual scientific forum that will bring together Sanofi-Aventis and university researchers to share knowledge and opinions on relevant scientific matters and to review progress of research projects funded through the collaboration." Fierce Biotech's John Carroll adds that this deal follows a similar one between Pfizer and Washington University, in which the two parties agreed to collaborate on re-purposing approximately 500 molecules. Carroll expects to "see more of these tie-ups between Big Pharma and universities as the industry continues its push for new drugs that can replace the blockbusters on the verge of losing patent protection," he writes.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.